If a sermorelin package arrives damaged or outside its labeled storage conditions, set it aside and contact the dispensing pharmacy before using it. A melted cold pack, a late tracking scan, or a vial that feels cool cannot independently establish the medicine’s condition.

There is no universal number of warm hours that applies to every compounded sermorelin product. The answer depends on the actual formulation and the pharmacy’s stability information. This guide focuses on documenting the shipment so the pharmacy can make a product-specific assessment.

The considered take

Record the delivery facts and get a pharmacy decision. Do not borrow a storage window from another brand, peptide, or dosage form.

Check the label and preserve the delivery details

Read the enclosed storage instructions first. Record the delivery time, when you opened the package, any visible damage, and the tracking history. Photograph leaking packaging, broken seals, or an indicator supplied with the shipment. Save the outer packaging until the pharmacy explains whether it needs anything for an investigation.

Record an actual temperature only if you have a meaningful measurement. Do not turn “felt warm” into an invented degree reading or assume the outside weather was the vial's temperature. If you do not know how long the parcel was on the doorstep, state that uncertainty.

Sources: FDA: Safe drug use after a natural disaster · FDA: Risks of compounded drugs

Ask for an answer tied to your prescription

Give the pharmacy the prescription number, formulation, lot information if present, and beyond-use date. Ask whether the described exposure falls within its supported conditions and whether the product should be replaced. A generic customer-service reassurance may not answer the stability question.

FDA's temperature guidance advises checking storage instructions or contacting a pharmacist or other appropriate professional when a refrigerated medicine has not been kept at the recommended temperature. That principle does not supply an allowable excursion for sermorelin. Our storage and travel guide covers routine planning before a problem occurs.

Sources: FDA: Safe drug use after a natural disaster

Do not try to repair a questionable shipment

Refrigerating a warm vial does not prove that its potency or sterility is restored. Do not freeze it to compensate, add liquid, or transfer it into another container. Follow the label while awaiting instructions, and keep a questionable vial separate from medicine cleared for use.

An unopened powder, a prepared injection, and a dissolving tablet are different products. Instructions for one cannot settle another. The reconstitution guide explains why preparation changes the questions about concentration and beyond-use dating.

Sources: FDA: Risks of compounded drugs · FDA: Compounding questions and answers · Mayo Clinic: Sermorelin injection information

Resolve replacements and refill timing separately

Ask who authorizes a replacement, whether there is a charge, and whether the next automatic shipment needs to move. Keep the support case number and written outcome. Do not place a duplicate paid order simply because a tracking update is late without first checking the original order's status.

Maximus, for example, directs patients with damaged or compromised shipments to support and separates shipping help from clinical questions. Other providers may use different procedures. If a delay affects the prescribed schedule, ask the clinician what to do; do not double the next amount to catch up. See subscriptions and refunds for the billing side.

Sources: Maximus: Sermorelin prescriptions, refills and shipping · Mayo Clinic: Sermorelin injection information

Sources behind this article

Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.

  1. FDA: Safe drug use after a natural disasterUS regulator · General temperature-exposure guidance. Does not establish a sermorelin stability window or injectable reconstitution method.
  2. FDA: Risks of compounded drugsUS regulator · Explains lack of FDA approval and the risks of poor-quality compounded preparations.
  3. FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
  4. Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
  5. Maximus: Sermorelin prescriptions, refills and shippingProvider help center · Explains clinician review, pharmacy fulfillment and support roles; not a tested service guarantee.